RADICAVA® (edaravone) IV infusion HCP Portal

 

Radicava Pack

Essential Information & Resources for RADICAVA IV infusion

Infusion Guide

Learn more

Infusion Quick Guide

Learn more
Doctor

HCP Booklet

Learn more
Patient Blooklet

Patient Blooklet

Learn more

Product Information

Learn more
A woman is shopping at a pharmacy.

Consumer Information

Learn more
PBS Information: Authority Required. This product is listed on the PBS as a Section 100 item. 
Refer to PBS Schedule for full authority information.


This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. 
Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems.

For Adverse Event Reporting please contact Medical Information Tel: 1800 288 382

PLEASE REVIEW PRODUCT INFORMATION BEFORE PRESCRIBING. 
The Product Information can be accessed at https://rss.medsinfo.com.au/tb/pi.cfm?product=tbpradic or from Medical Information on 1800 AU TEVA (1800 28 8382) or by scanning the QR code. 

Teva Pharma Australia Pty Ltd (ABN 41 169 715 664) Level 1, 37 Epping Road, Macquarie Park, NSW 2113 Australia.
Phone: 1800 AU TEVA (1800 288 382)
www.tevapharma.com.au

Date of preparation: April 2025, RAD-AU-00020.  Date of expiration: April 2027.